<- Go Home
LTT Bio-Pharma Co.,Ltd.
LTT Bio-Pharma Co., Ltd. engages in the research and development of drugs and technologies, etc. primarily in Japan. Its products include prostaglandin E1 formulations for intravenous injections; nonsteroidal anti-inflammatory formulations for intravenous injections; transdermal steroid formulations; and halopredone acetate formulations, as well as lipo-PGE1, a drug delivery system. The company also develops a therapeutic agent, which is in Phase II clinical trial for treating dry eyes. LTT Bio-Pharma Co., Ltd. was founded in 1988 and is based in Tokyo, Japan.
Market Cap
N/A
Volume
3.6K
Cash and Equivalents
N/A
EBITDA
-JPY 445.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
JPY 61.0M
Profit Margin
100.00%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-JPY 446.0M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
N/A
Debt
N/A
Equity
N/A
Revenue
JPY 61.0M
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A